RWC-340B releases analysis warning federal and state policymakers of drug industry disinformation campaign. “RWC-340B will not stand idle while the pharmaceutical industry attacks safety net providers in the 340B…
RWC-340B President, Shannon Stephenson, submitted comments to HRSA in response to the Information Collection Request (ICR), issued by the Health Resources and Services Administration (HRSA). In the submission, RWC-340B made…
Click below to see RWC-340B’s Press Statement PrEP BIll Press Statement RWC-340B
RWC-340B President, Shannon Stephenson, received a response to the May 4th follow-up and original letters sent to Gilead. Click Here to see Gilead’s response, and Click Here to read Shannon’s…
As you may know, the Federal Trade Commission recently requested public comments on the impacts of Pharmacy Benefit Managers’ practices, affecting drug affordability and access. Today, RWC-340B submitted detailed…
A growing number of pharmaceutical manufacturers have recently posed restrictions affecting Ryan White Clinics and other Safety Net Providers. RWC-340B has taken action to address these challenges head-on. On…
By letter dated March 21, 2021, Johnson & Johnson (J&J) announced that, effective May 2, 2022, it will no longer honor bill-to/ship-to orders for contract pharmacy arrangements with hospitals unless…
Trent Smith is the Managing Director for RWC-340B under UPHS and brings experience from both the nonprofit and for-profit sectors, having worked within the Southern Scholarship Foundation Community and then…
As reported today in the 340B Report, Health Care Provider Groups Slam Gilead’s Conditions on 340B Contract Pharmacy (for subscribers only), and RWC-340B President Shannon Stephenson is quoted throughout (excerpt below). Ryan White…
By letter dated March 15, 2022, Gilead announced that, effective May 2, 2022, it will implement a new “Contract Pharmacy Integrity Initiative” under which it will no longer honor contract…